CN106845155B - 一种用于检测内部串联重复的装置 - Google Patents
一种用于检测内部串联重复的装置 Download PDFInfo
- Publication number
- CN106845155B CN106845155B CN201710067187.0A CN201710067187A CN106845155B CN 106845155 B CN106845155 B CN 106845155B CN 201710067187 A CN201710067187 A CN 201710067187A CN 106845155 B CN106845155 B CN 106845155B
- Authority
- CN
- China
- Prior art keywords
- breakpoint
- itd
- module
- sequencing
- information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012163 sequencing technique Methods 0.000 claims abstract description 148
- 238000001514 detection method Methods 0.000 claims abstract description 34
- 239000012634 fragment Substances 0.000 claims description 128
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 238000012216 screening Methods 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 description 34
- 239000011324 bead Substances 0.000 description 31
- 238000000034 method Methods 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 12
- 101150054338 ref gene Proteins 0.000 description 12
- 210000000349 chromosome Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000000746 purification Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 210000001185 bone marrow Anatomy 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 235000019506 cigar Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000003252 repetitive effect Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 4
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001821 nucleic acid purification Methods 0.000 description 3
- 208000019838 Blood disease Diseases 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 108010003374 fms-Like Tyrosine Kinase 3 Proteins 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000018706 hematopoietic system disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000012487 rinsing solution Substances 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 238000000729 Fisher's exact test Methods 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 101100335080 Homo sapiens FLT3 gene Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 102000016548 Vascular Endothelial Growth Factor Receptor-1 Human genes 0.000 description 1
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 210000003918 fraction a Anatomy 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011140 membrane chromatography Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 1
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
检出个数 | 阳性位点个数 | 阳性率 | |
比较例1的装置 | 8 | 8 | 4.14±8.16% |
实施例1的装置 | 1 | 1 | 41.15% |
Claims (7)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611245116 | 2016-12-29 | ||
CN2016112451167 | 2016-12-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106845155A CN106845155A (zh) | 2017-06-13 |
CN106845155B true CN106845155B (zh) | 2021-11-16 |
Family
ID=59122958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710067187.0A Active CN106845155B (zh) | 2016-12-29 | 2017-02-07 | 一种用于检测内部串联重复的装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106845155B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107451428B (zh) * | 2017-08-02 | 2020-05-22 | 广东国盛医学科技有限公司 | 下一代测序中末端短串联序列的优化处理方法 |
CN107368708B (zh) * | 2017-08-14 | 2018-03-16 | 东莞博奥木华基因科技有限公司 | 一种精准分析dmd基因结构变异断点的方法及系统 |
CN109943635A (zh) * | 2017-12-21 | 2019-06-28 | 安诺优达基因科技(北京)有限公司 | 一种用于flt3-itd定量检测的装置 |
CN111863133B (zh) * | 2019-12-30 | 2023-07-18 | 上海交通大学医学院附属瑞金医院 | 一种高通量测序数据的分析方法、试剂盒及分析系统 |
CN111243663B (zh) * | 2020-02-26 | 2022-06-07 | 西安交通大学 | 一种基于模式增长算法的基因变异检测方法 |
CN114328399B (zh) * | 2022-03-15 | 2022-05-24 | 四川大学华西医院 | 一种基因测序多样本数据文件自动配对的方法和系统 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007011312A1 (en) * | 2005-07-19 | 2007-01-25 | Temasek Life Sciences Laboratory Limited | Fish cancer model |
CN101014719A (zh) * | 2004-03-25 | 2007-08-08 | 基尼宗生物科学公司 | 核酸测序的方法和手段 |
CN101560564A (zh) * | 2009-04-08 | 2009-10-21 | 北京华生恒业科技有限公司 | 一种检测装置及系统 |
CN101680872A (zh) * | 2007-04-13 | 2010-03-24 | 塞昆纳姆股份有限公司 | 序列比较分析方法和系统 |
CN103902852A (zh) * | 2014-03-21 | 2014-07-02 | 深圳华大基因科技有限公司 | 基因表达的定量方法及装置 |
CN104302781A (zh) * | 2013-05-15 | 2015-01-21 | 深圳华大基因科技有限公司 | 一种检测染色体结构异常的方法及装置 |
CN105441427A (zh) * | 2014-08-07 | 2016-03-30 | 中国农业科学院作物科学研究所 | 一种冰草染色体端部特异的串联重复序列及其应用 |
CN106202991A (zh) * | 2016-06-30 | 2016-12-07 | 厦门艾德生物医药科技股份有限公司 | 一种基因组多重扩增测序产物中突变信息的检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130345066A1 (en) * | 2012-05-09 | 2013-12-26 | Life Technologies Corporation | Systems and methods for identifying sequence variation |
WO2014078739A1 (en) * | 2012-11-15 | 2014-05-22 | The General Hospital Corporation | Methods and systems for diagnosing prenatal abnormalities |
KR20160039386A (ko) * | 2014-10-01 | 2016-04-11 | 삼성에스디에스 주식회사 | Itd 검출 장치 및 방법 |
CN104789686B (zh) * | 2015-05-06 | 2018-09-07 | 浙江安诺优达生物科技有限公司 | 检测染色体非整倍性的试剂盒和装置 |
-
2017
- 2017-02-07 CN CN201710067187.0A patent/CN106845155B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101014719A (zh) * | 2004-03-25 | 2007-08-08 | 基尼宗生物科学公司 | 核酸测序的方法和手段 |
WO2007011312A1 (en) * | 2005-07-19 | 2007-01-25 | Temasek Life Sciences Laboratory Limited | Fish cancer model |
CN101680872A (zh) * | 2007-04-13 | 2010-03-24 | 塞昆纳姆股份有限公司 | 序列比较分析方法和系统 |
CN101560564A (zh) * | 2009-04-08 | 2009-10-21 | 北京华生恒业科技有限公司 | 一种检测装置及系统 |
CN104302781A (zh) * | 2013-05-15 | 2015-01-21 | 深圳华大基因科技有限公司 | 一种检测染色体结构异常的方法及装置 |
CN103902852A (zh) * | 2014-03-21 | 2014-07-02 | 深圳华大基因科技有限公司 | 基因表达的定量方法及装置 |
CN105441427A (zh) * | 2014-08-07 | 2016-03-30 | 中国农业科学院作物科学研究所 | 一种冰草染色体端部特异的串联重复序列及其应用 |
CN106202991A (zh) * | 2016-06-30 | 2016-12-07 | 厦门艾德生物医药科技股份有限公司 | 一种基因组多重扩增测序产物中突变信息的检测方法 |
Non-Patent Citations (1)
Title |
---|
双重PCR检测急性髓系白血病FLT3-ITD和NPM1基因突变;张泽川 等;《中国实验血液学杂志》;20110331;第19卷(第3期);717-720 * |
Also Published As
Publication number | Publication date |
---|---|
CN106845155A (zh) | 2017-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106845155B (zh) | 一种用于检测内部串联重复的装置 | |
CN106845150B (zh) | 一种用于检测循环肿瘤dna样本基因融合的装置 | |
JP6830496B2 (ja) | 遺伝子突然変異を検出するマルチポジショニングダブルタグアダプターセット、及びその調製方法と応用 | |
CN110211633B (zh) | Mgmt基因启动子甲基化的检测方法、测序数据的处理方法及处理装置 | |
CN108595918B (zh) | 循环肿瘤dna重复序列的处理方法及装置 | |
CN111073961A (zh) | 一种基因稀有突变的高通量检测方法 | |
CN113373524B (zh) | 一种ctDNA测序标签接头、文库、检测方法和试剂盒 | |
CN106845154B (zh) | 一种用于ffpe样本拷贝数变异检测的装置 | |
CN111534602A (zh) | 一种基于高通量测序分析人类血型基因型的方法及其应用 | |
CN106815491B (zh) | 一种用于检测ffpe样本基因融合的装置 | |
CN111705135A (zh) | 一种检测mgmt启动子区甲基化的方法 | |
CN107077538B (zh) | 测序数据处理装置和方法 | |
CN113265452A (zh) | 一种基于Nanopore宏基因组RNA-seq的生物信息学检测病原体的方法 | |
CN111304309A (zh) | 一种测序平台标签序列污染的检测方法 | |
CN111944806A (zh) | 一种高通量测序污染检测用分子标签组及其应用 | |
CN116463408A (zh) | 一种abo基因扩增引物、扩增体系、扩增方法、测序文库构建方法及测序方法 | |
CN112442530A (zh) | 检测cah相关真假基因的方法 | |
CN111020710A (zh) | 造血及淋巴组织肿瘤的ctDNA高通量检测 | |
CN114854737A (zh) | 基于三代测序平台的i类hla基因扩增引物、试剂盒及分型方法 | |
CN114250269A (zh) | 一种探针组合物、基于该探针组合物的二代测序文库及其应用 | |
CN105603052B (zh) | 探针及其用途 | |
CN113981059B (zh) | 一种地中海贫血症突变基因检测引物组合物及其试剂 | |
CN114807302B (zh) | 扩增子文库构建方法及用于地中海贫血突变型与缺失型基因检测的试剂盒 | |
CN115620809B (zh) | 纳米孔测序数据分析方法、装置以及存储介质和应用 | |
Zurek et al. | UMI-linked nanopore consensus sequencing (UMIC-seq) of highly similar gene variants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171215 Address after: 100176 Beijing branch of Beijing economic and Technological Development Zone Street 88 Hospital No. 8 Building 2 unit 701 room Applicant after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Applicant after: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Applicant after: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. Address before: 100176 Beijing branch of Daxing District economic and Technological Development Zone Street 88 Hospital No. 8 Building 2 unit 701 room Applicant before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240403 Address after: Room 701, unit 2, building 8, yard 88, Kechuang 6th Street, Daxing District, Beijing 100176 Patentee after: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Country or region after: China Patentee after: BEIJING ANNOROAD MEDICAL LABORATORY Co.,Ltd. Address before: 100176 room 701, unit 2, building 8, courtyard 88, Kechuang 6th Street, Beijing Economic and Technological Development Zone, Beijing Patentee before: ANNOROAD GENE TECHNOLOGY (BEIJING) Co.,Ltd. Country or region before: China Patentee before: ZHEJIANG ANNOROAD BIO-TECHNOLOGY Co.,Ltd. Patentee before: ANNOROAD (YIWU) MEDICAL INSPECTION CO.,LTD. |
|
TR01 | Transfer of patent right |